| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 8.68▲ | 8.69▲ | 8.72▲ | 8.79▼ | 8.99▼ |
| MA10 | 8.63▲ | 8.76▼ | 8.83▼ | 8.74▼ | 8.44▲ |
| MA20 | 8.66▲ | 8.82▼ | 8.81▼ | 9.28▼ | 6.94▲ |
| MA50 | 8.78▼ | 8.85▼ | 8.80▼ | 8.25▲ | 4.32▲ |
| MA100 | 8.80▼ | 8.75▼ | 8.87▼ | 6.66▲ | 3.13▲ |
| MA200 | 8.81▼ | 9.00▼ | 9.18▼ | 4.61▲ | 2.90▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.019▲ | -0.022▼ | -0.019▼ | -0.125▼ | 0.107▲ |
| RSI | 53.526▲ | 47.737▼ | 47.663▼ | 49.336▼ | 65.134▲ |
| STOCH | 83.229▲ | 21.105 | 40.869 | 48.810 | 66.756 |
| WILL %R | -14.286▲ | -70.492 | -48.864 | -64.988 | -38.761 |
| CCI | 154.725▲ | -92.005 | -36.227 | -13.715 | 53.396 |
|
Wednesday, March 25, 2026 10:05 AM
Immix Biopharma (IMMX) stock rises as Morgan Stanley starts coverage on the company with an overweight recommendation, citing its lead asset NXC-201. Read more here.
|
|
Monday, March 23, 2026 12:17 AM
Monday Economic Lookahead Construction spending (delayed report) (Jan.) Featured Earnings ...
|
|
Sunday, March 22, 2026 08:34 PM
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at media & entertainment stocks, starting ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 08/04/26 | 9.17 | 9.17 | 8.55 | 8.73 | 477,464 |
| 07/04/26 | 8.50 | 9.18 | 8.26 | 9.09 | 855,815 |
| 06/04/26 | 8.97 | 9.31 | 8.51 | 8.59 | 544,223 |
| 02/04/26 | 8.50 | 9.28 | 8.40 | 8.94 | 418,141 |
| 01/04/26 | 9.23 | 9.60 | 8.54 | 8.62 | 679,837 |
| 31/03/26 | 8.85 | 9.16 | 8.13 | 9.11 | 1,221,830 |
| 30/03/26 | 8.19 | 8.7999 | 8.01 | 8.58 | 912,349 |
| 27/03/26 | 8.97 | 9.1899 | 8.00 | 8.15 | 750,582 |
| 26/03/26 | 8.13 | 9.52 | 8.12 | 8.72 | 1,045,482 |
| 25/03/26 | 9.14 | 9.35 | 8.72 | 8.91 | 768,748 |
|
|
||||
|
|
||||
|
|